 - Receipt of systemic glucocorticoids within 30 days prior to the first dose of study vaccineplacebo, or any other cytotoxic, immunosuppressive or immune-modifying drugs within 6 months of first study vaccineplacebo dose. Topical, intra-articularly injected, or inhaled glucocorticoids, topical calcineurin inhibitors or imiquimod are allowed. 